Question:
In "Intellectual Property and Pharmaceutical Drugs: An Ethical Analysis," Richard T. De George lays out what he comes to call the "Status Quo Approach" as a defense of copyright protection of pharmaceuticals. Do you find this argument persuasive regarding ethical pricing of pharmaceuticals? Why, or why not?